200 related articles for article (PubMed ID: 8116999)
1. Clinical uses of insulin-like growth factor I.
Bondy CA; Underwood LE; Clemmons DR; Guler HP; Bach MA; Skarulis M
Ann Intern Med; 1994 Apr; 120(7):593-601. PubMed ID: 8116999
[TBL] [Abstract][Full Text] [Related]
2. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
4. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
5. Clinical uses of insulin-like growth factor I.
Hussain MA; Froesch ER
Adv Endocrinol Metab; 1995; 6():143-65. PubMed ID: 7671094
[No Abstract] [Full Text] [Related]
6. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus.
Mohamed-Ali V; Pinkney J
Treat Endocrinol; 2002; 1(6):399-410. PubMed ID: 15832492
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance.
Froesch ER; Bianda T; Hussain MA
Diabetes Metab; 1996 Jul; 22(4):261-7. PubMed ID: 8767173
[TBL] [Abstract][Full Text] [Related]
9. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
Clemmons DR
Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
[TBL] [Abstract][Full Text] [Related]
10. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
11. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and therapeutic effects of insulin-like growth factor I.
Froesch ER; Zenobi PD; Hussain M
Horm Res; 1994; 42(1-2):66-71. PubMed ID: 7959637
[TBL] [Abstract][Full Text] [Related]
13. Is there a medical need to explore the clinical use of insulin-like growth factor I?
Savage MO; Camacho-Hübner C; Dunger DB; Ranke MB; Ross RJ; Rosenfeld RG
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S65-9. PubMed ID: 11527091
[TBL] [Abstract][Full Text] [Related]
14. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
Dunger DB; Acerini CL
Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks.
Kolaczynski JW; Caro JF
Ann Intern Med; 1994 Jan; 120(1):47-55. PubMed ID: 8250456
[TBL] [Abstract][Full Text] [Related]
16. Therapy with recombinant human insulin-like growth factor I in children with insensitivity to growth hormone and in catabolic conditions.
Underwood LE; Backeljauw P
J Intern Med; 1993 Dec; 234(6):571-7. PubMed ID: 8258748
[No Abstract] [Full Text] [Related]
17. Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus.
Froesch ER; Hussain M
Diabetologia; 1994 Sep; 37 Suppl 2():S179-85. PubMed ID: 7821734
[TBL] [Abstract][Full Text] [Related]
18. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 1 (IGF-1): a growth hormone.
Laron Z
Mol Pathol; 2001 Oct; 54(5):311-6. PubMed ID: 11577173
[TBL] [Abstract][Full Text] [Related]
20. Can growth hormone counteract the catabolic effects of steroids?
Mauras N
Horm Res; 2009 Nov; 72 Suppl 1():48-54. PubMed ID: 19940496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
